A dual chamber model of female cervical mucosa for the study of HIV transmission and for the evaluation of candidate HIV microbicides

Antiviral Research

Volumn 74, Issue 2, 2007, Pages 111-124

  Van Herrewege, Yven ^a   Michiels, Jo ^a   Waeytens, Anouk ^b   De Boeck, Gitte ^b   Salden, Evelyne ^a   Heyndrickx, Leo ^a   van den Mooter, Guy ^c   de Béthune, Marie Pierre ^d   Andries, Koen ^d   Lewi, Paul ^e   Praet, Marleen ^b   Vanham, Guido ^a,f  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Virco BVBA   (Belgium)

^e CMD   (Belgium)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Dendritic cells; Entry inhibitors; In vitro model; Microbicides; NNRTI; Sexual HIV transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIGEN P24; CELLULOSE SULFATE; COLCHICINE; DAPIVIRINE; DEXTRAN SULFATE; DS 5000; ENFUVIRTIDE; ETRAVIRINE; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; PLACEBO; POLYSTYRENESULFONIC ACID; PRO 2000; PYRIMIDINE DERIVATIVE; R 151694; R 152929; R 153430; RILPIVIRINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; DRUG FORMULATION; DRUG POTENCY; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FEMALE GENITAL TRACT INFECTION; FLOW CYTOMETRY; GEL; HETEROSEXUALITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MODEL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX EPITHELIUM; UTERINE CERVIX MUCOSA; VIRUS INFECTION; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL LINE; CELLS, CULTURED; CERVIX UTERI; COCULTURE TECHNIQUES; DENDRITIC CELLS; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; MICROSCOPY, CONFOCAL; MUCOUS MEMBRANE;

EID: 33947401108     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2006.10.010     Document Type: Article

References (61)

1. Alfsen A., Yu H., Magérus-Chatinet A., Schmitt A., and Bomsel M. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across an epithelial cell monolayer. Mol. Biol. Cell. 16 (2005) 4267-4279
2. Andries K., Azijn H., Thielemans T., Ludovici D., Kukla M., Heeres J., Janssen P., De Corte B., Vingerhoets J., Pauwels R., and de Béthune M.P. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 48 (2004) 4680-4686
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Beirnaert E., Willems B., Peeters M., Bouckaert A., Heyndrickx L., Zhong P., Vereecken K., Coppens S., Davis D., Ndumbe P., Janssens W., and van der Groen G. Design and evaluation of an in-house HIV-1 (group M and O), SIVmnd and SIVcpz antigen capture assay. J. Virol. Methods 73 (1998) 65-70
5. Blocker M.E., and Cohen M.S. Biologic approaches to the prevention of sexual transmission of human immunodeficiency virus. Infect. Dis. Clin. North Am. 14 (2000) 983-999
6. Bomsel M., Prydz K., Parton R.G., Gruenberg J., and Simons K. Endocytosis in filter-grown Madin-Darby canine kidney cells. J. Cell Biol. 109 (1989) 3243-3258
7. Bomsel M., and Mostov K.E. Sorting of plasma membrane proteins in epithelial cells. Curr. Opin. Cell Biol. 3 (1991) 647-653
8. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3 (1997) 42-47
9. Chan D.J. Pathophysiology of HIV-1 in semen: current evidence for compartmentalisation and penetration by antiretroviral drugs. Curr. HIV Res. 3 (2005) 207-222
10. Clemetson D.B., Moss G.B., Willerford D.M., Hensel M., Emonyi W., Holmes K.K., Plummer F., Ndinya-Achola J., Roberts P.L., and Hillier S. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 269 (1993) 2860-2864
11. Collins K.B., Patterson B.K., Naus G.J., Landers D.V., and Gupta P. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat. Med. 6 (2000) 475-479
12. D'Cruz O.J., and Uckun F.M. Clinical development of microbicides for the prevention of HIV infection. Curr. Pharm. Des. 10 (2004) 315-336
13. Dezzutti C.S., Guenthner P.C., Cummins Jr. J.E., Cabrera T., Marshall J.H., Dillberger A., and Lal R.B. Cervical and prostate primary epithelial cells are not productively infected but sequester human immunodeficiency virus type 1. J. Infect. Dis. 183 (2001) 1204-1213
14. Dhondt M.M., Adriaens E., and Remon J.P. The evaluation of the local tolerance of vaginal formulations, with or without nonoxynol-9, using the slug mucosal irritation test. Sex. Transm. Dis. 31 (2004) 229-235
15. Di Fabio S., Van Roey J., Giannini G., van den Mooter G., Spada M., Binelli A., Pirillo M.F., Germinario E., Belardelli F., de Béthune M.P., and Vella S. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS 17 (2003) 1597-1604
16. Elias C.J., and Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 10 Suppl. 3 (1996) S43-S51
17. El Messaoudi K., Thiry L., Van Tieghem N., Liesnard C., Englert Y., Moguilevsky N., and Bollen A. HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions. AIDS 13 (1999) 333-339
18. Fais S., Capobianchi M.R., Abbate I., Castilletti C., Gentile M., Cordiali F.P., Ameglio F., and Dianzani F. Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS 9 (1995) 329-335
19. Greenhead P., Hayes P., Watts P.S., Laing K.G., Griffin G.E., and Shattock R.J. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J. Virol. 74 (2000) 5577-5586
20. Hart C.E., Lennox J.L., Pratt-Palmore M., Wright T.C., Schinazi R.F., Evans-Strickfaden T., Bush T.J., Schnell C., Conley L.J., Clancy K.A., and Ellerbrock T.V. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J. Infect. Dis. 179 (1999) 871-882
21. Hocini H., and Bomsel M. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. J. Infect. Dis. 179 Suppl. 3 (1999) S448-S453
22. Hocini H., Becquart P., Bouhlal H., Chomont N., Ancuta P., Kazatchkine M.D., and Belec L. Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells. J. Virol. 75 (2001) 5370-5374
23. Hu J., Gardner M.B., and Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74 (2000) 6087-6095
24. Janssen P.A., Lewi P.J., Arnold E., Daeyaert F., de Jonge M., Heeres J., Koymans L., Vinkers M., Guillemont J., Pasquier E., Kukla M., Ludovici D., Andries K., de Béthune M.P., Pauwels R., Das K., Clark Jr. A.D., Frenkel Y.V., Hughes S.H., Medaer B., De Knaep F., Bohets H., De Clerck F., Lampo A., Williams P., and Stoffels P. In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). J. Med. Chem. 48 (2005) 1901-1909
25. Kawamura T., Cohen S.S., Borris D.L., Aquilino E.A., Glushakova S., Margolis L.B., Orenstein J.M., Offord R.E., Neurath A.R., and Blauvelt A. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J. Exp. Med. 192 (2000) 1491-1500
26. Keller M.J., Zerhouni-Layachi B., Cheshenko N., John M., Hogarty K., Kasowitz A., Goldberg C.L., Wallenstein S., Profy A.T., Klotman M.E., and Herold B.C. PRO2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J. Infect. Dis. 193 (2006) 27-35
27. Ludovici D.W., Kavash R.W., Kukla M.J., Ho C.Y., Ye H., De Corte B.L., Andries K., de Béthune M.P., Azijn H., Pauwels R., Moereels H.E., Heeres J., Koymans L.M., de Jonge M.R., Van Aken K.J., Daeyaert F.F., Lewi P.J., Das K., Arnold E., and Janssen P.A. Evolution of anti-HIV drug candidates. Part 2: diaryltriazine (DATA) analogues. Bioorg. Med. Chem. Lett. 11 (2001) 2229-2234
28. Ludovici D.W., De Corte B.L., Kukla M.J., Ye H., Ho C.Y., Lichtenstein M.A., Kavash R.W., Andries K., de Béthune M.P., Azijn H., Pauwels R., Lewi P.J., Heeres J., Koymans L.M., de Jonge M.R., Van Aken K.J., Daeyaert F.F., Das K., Arnold E., and Janssen P.A. Evolution of anti-HIV drug candidates. Part 3: diarylpyrimidine (DAPY) analogues. Bioorg. Med. Chem. Lett. 11 (2001) 2235-2239
29. Mayer K.H., and Anderson D.J. Heterosexual HIV transmission. Infect. Agents Dis. 4 (1995) 273-284
30. McCormack S., Hayes R., Lacey C.J., and Johnson A.M. Microbicides in HIV prevention. BMJ 322 (2001) 410-413
31. + cells. Nat. Med. 8 (2002) 150-156
32. Miller C.J., Vogel P., Alexander N.J., Sutjipto S., Hendrickx A.G., and Marx P.A. Localization of SIV in the genital tract of chronically infected female rhesus macaques. Am. J. Pathol. 141 (1992) 655-660
33. Moench T.R., Doncel G., and Cone R.A. The HEC placebo: designed for "no effect". Microbicides 2004 Conference Abstracts. Microbicides Development Program, London (2004) 115 Abstract 02609
34. Moulard M., Lortat-Jacob H., Mondor I., Roca G., Wyatt R., Sodroski J., Zhao L., Olson W., Kwong P.D., and Sattentau Q.J. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J. Virol. 74 (2000) 1948-1960
35. Padian N.S., Shiboski S.C., Glass S.O., and Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am. J. Epidemiol. 146 (1997) 350-357
36. Palacio J., Souberbielle B.E., Shattock R.J., Robinson G., Manyonda I., and Griffin G.E. In vitro HIV1 infection of human cervical tissue. Res. Virol. 145 (1994) 155-161
37. Pearce-Pratt R., and Phillips D.M. Studies of adhesion of lymphocytic cells: implications for sexual transmission of human immunodeficiency virus. Biol. Reprod. 48 (1993) 431-445
38. Pearce-Pratt R., Malamud D., and Phillips D.M. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J. Virol. 68 (1994) 2898-2905
39. Peden K., and Martin M. Virological and molecular genetic techniques for studies of established HIV isolates. In: Karn J. (Ed). A Practical Approach to HIV Virology and Immunology (1995), Oxford University Press, New York 21-45
40. Phillips D.M. The role of cell-to-cell transmission in HIV infection. AIDS 8 (1994) 719-731
41. Phillips D.M., Taylor C.L., Zacharopoulos V.R., and Maguire R.A. Nonoxynol-9 causes rapid exfoliation of sheets of rectal epithelium. Contraception 62 (2000) 149-154
42. Pilcher C.D., Tien H.C., Eron Jr. J.J., Vernazza P.L., Leu S.Y., Stewart P.W., Goh L.E., and Cohen M.S. Brief but efficient: acute HIV infection and the sexual transmission of HIV. J. Infect. Dis. 189 (2004) 1785-1792
43. Pudney J., Quayle A.J., and Anderson D.J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73 (2005) 1253-1263
44. Quayle A.J., Xu C., Mayer K.H., and Anderson D.J. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J. Infect. Dis. 176 (1997) 960-968
45. Reed L.J., and Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27 (1938) 493-497
46. Servet C., Zitvogel L., and Hosmalin A. Dendritic cells in innate immune responses against HIV. Curr. Mol. Med. 2 (2002) 739-756
47. Shattock R.J., and Moore J.P. Inhibiting sexual transmission of HIV-1 infection. Nat. Rev. Microbiol. 1 (2003) 25-34
48. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., and Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J. Exp. Med. 183 (1996) 215-225
49. Stafford M.K., Ward H., Flanagan A., Rosenstein I.J., Taylor-Robinson D., Smith J.R., Weber J., and Kitchen V.S. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17 (1998) 327-331
50. Sugaya M., Lore K., Koup R.A., Douek D.C., and Blauvelt A. HIV-infected Langerhans cells preferentially transmit virus to proliferating autologous CD4+ memory T cells located within Langerhans cell-T cell clusters. J. Immunol. 172 (2004) 2219-2224
51. Tan X., Pearce-Pratt R., and Phillips D.M. Productive infection of a cervical epithelial cell line with human immunodeficiency virus: implications for sexual transmission. J. Virol. 67 (1993) 6447-6452
52. Tien D., Schnaare R.L., Kang F., Cohl G., McCormick T.J., Moench T.R., Doncel G., Watson K., Buckheit R.W., Lewis M.G., Schwartz J., Douville K., and Romano J.W. In vitro and in vivo characterization of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res. Hum. Retroviruses 21 (2005) 845-853
53. Turpin J.A. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin. Investig. Drugs 11 (2002) 1077-1097
54. UNAIDS, UNAIDS Global Fact Sheet 22-07-2005, http://www.unaids.org
55. Van Damme L., Wright A., Depraetere K., Rosenstein I., Vandersmissen V., Poulter L., McKinlay M., Van Dyck E., Weber J., Profy A., Laga M., and Kitchen V. A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women. Sex. Transm. Infect. 76 (2000) 126-130
56. Van Damme L., Ramjee G., Alary M., Vuylsteke B., Chandeying V., Rees H., Sirivongrangson P., Mukenge-Tshibaka L., Ettiegne-Traore V., Uaheowitchai C., Karim S.S., Masse B., Perriens J., and Laga M. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360 (2002) 971-977
57. Van Herrewege Y., Penne L., Vereecken C., Fransen K., van der Groen G., Kestens L., Balzarini J., and Vanham G. Activity of reverse transcriptase inhibitors in monocyte-derived dendritic cells: a possible in vitro model for postexposure prophylaxis of sexual HIV transmission. AIDS Res. Hum. Retroviruses 18 (2002) 1091-1102
58. Van Herrewege Y., Michiels J., Van Roey J., Fransen K., Kestens L., Balzarini J., Lewi P., Vanham G., and Janssen P. In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrob. Agents Chemother. 48 (2004) 337-339
59. Van Herrewege Y., Vanham G., Michiels J., Fransen K., Kestens L., Andries K., Janssen P., and Lewi P. A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicides. Antimicrob. Agents Chemother. 48 (2004) 3684-3689
60. Veazey R.S., Shattock R.J., Pope M., Kirijan J.C., Jones J., Hu Q., Ketas T., Marx P.A., Klasse P.J., Burton D.R., and Moore J.P. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9 (2003) 343-346
61. Vernazza P.L., Gilliam B.L., Dyer J., Fiscus S.A., Eron J.J., Frank A.C., and Cohen M.S. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 11 (1997) 987-993